Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BIMO Director Konnor Is Among Device Veterans To Retire By Year-End

This article was originally published in The Gray Sheet

Executive Summary

CDRH Bioresearch Monitoring Division Director Charma Konnor will remain involved in FDA-related activities after officially retiring Jan. 3, 2003

You may also be interested in...



OC Director Appointment Expected In Early 2003; Reorganization Wrapping Up

FDA plans to conduct interviews for the CDRH Office of Compliance director position during the week of Dec. 9

OC Director Appointment Expected In Early 2003; Reorganization Wrapping Up

FDA plans to conduct interviews for the CDRH Office of Compliance director position during the week of Dec. 9

FDA News In Brief

Abbreviated 510(k) project update: The Centers for Devices & Radiological Health is looking to finish, in the first quarter of 2003, collaborations with several manufacturers to draft abbreviated 510(k) summary reports, staffers say. An invitation to work with CDRH to create example summary reports serving as templates was extended to abbreviated 510(k) sponsors by the device center in June (1"The Gray Sheet" June 3, 2002, p. 3). Although CDRH has had inquiries from a number of manufacturers, not all have been fruitful, according to staffers, who are still searching for additional manufacturers with whom to collaborate on the initiative. The project is open to devices with Class II special controls final guidance documents...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel